Get started
Author

Imma Di Luna

Observed names: Di Luna, Imma, I Di Luna, I. Di Luna, Imma di Luna
Observed institutions: University College Cork, Cork University Hospital, Federico II University Hospital, Istituti Ospitalieri di Cremona, Azienda Socio Sanitaria Territoriale di Cremona, University of Naples Federico II
ORCID: 0009-0009-7240-9431
Observed ORCID: 0009-0009-7240-9431
OpenAlex ID: A5045344018
Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations
2022 · Cristina Bezzio, Cristina Della Corte, et al. · Therapeutic Advances in Gastroenterology · 63
PDF
Exploring the concept of deep remission in Crohn’s disease: correlation between transmural healing and biomarkers
2022 · Fabiana Castiglione, Nicola Imperatore, et al. · Therapeutic Advances in Gastroenterology · 18
Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience
2018 · Anna Testa, Eleonora Giannetti, et al. · Digestive and Liver Disease · 16
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study
2023 · Marietta Iacucci, Stefanos Bonovas, et al. · Gastrointestinal Endoscopy · 10
PDF
Long-term Major Papilla Metastasis From Lobular Breast Cancer Mimicking Ampullary Neoplasm: An Endoscopic Ultrasound Diagnosis
2023 · Stefano Mazza, Andrea Drago, et al. · The American Journal of Gastroenterology · 8
Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition
2024 · Olga Maria Nardone, Massimo Martinelli, et al. · Therapeutic Advances in Gastroenterology · 7
Ultrasonography-Based Management of Sclerosing Mesenteritis: From Diagnosis to Follow-Up
2021 · Roberto de Sire, Nicola Imperatore, et al. · International Medical Case Reports Journal · 3
PDF
Treatment‐based risk stratification of infections in inflammatory bowel disease: A comparison between anti‐tumor necrosis factor‐α and nonbiological exposure in real‐world setting
2020 · Nicola Imperatore, Maria Foggia, et al. · Journal of Gastroenterology and Hepatology · 3
Real‐World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease—A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases ( IG ‐ IBD )
2026 · Brigida Barberio, Ferdinando D'Amico, et al. · Alimentary Pharmacology & Therapeutics · 2
PDF
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves
2023 · Cristina Bezzio, Marta Vernero, et al. · BMC Gastroenterology · 2
PDF
Su1576: EFFECT OF TRANSITION CARE ON CLINICAL OUTCOMES AND TREATMENT ADHERENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: AN OBSERVATIONAL PROSPECTIVE STUDY
2022 · Olga Maria Nardone, Massimo Martinelli, et al. · Gastroenterology · 1
Chemotherapy-Induced Remission of Steroid-Dependent Ulcerative Colitis Associated With Rectal Hodgkin Lymphoma
2021 · Roberto de Sire, Fabiana Castiglione, et al. · Inflammatory Bowel Diseases · 1
Optimizing Endoscopy: The Impact of Specialist Triage on Diagnostic Accuracy
2026 · D Dagani, L Pignata, et al. · Endoscopy
Supporting MAPS III: Reassessing Gastric Cancer Surveillance in High-Incidence Areas
2026 · M M Sannino, L Pignata, et al. · Endoscopy
Reference range of pancreatic strain histograms using Endoscopic Ultrasound Elastography in healthy subjects: a pilot study
2026 · C Laurenza, N Zignani, et al. · Endoscopy
A New Error, A New Solution: Succesful Endoscopic Rescue Of A Type III Misdeployment During EUS-Guided Gastroenterostomy
2026 · F Frigo, B Elvo, et al. · Endoscopy
Su1630 UPADACITINIB: PERSONALIZED GOALS FOR REMISSION AND DISEASE EVALUATION IN PATIENTS WITH CROHN’S DISEASE (UPGRADE-CD) - A MULTICENTER PROSPECTIVE STUDY FROM THE ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASES (IG-IBD)
2026 · Brigida Barberio, Franco Scaldaferri, et al. · Gastroenterology
Su1630 UPADACITINIB: PERSONALIZED GOALS FOR REMISSION AND DISEASE EVALUATION IN PATIENTS WITH CROHN’S DISEASE (UPGRADE-CD) - A MULTICENTER PROSPECTIVE STUDY FROM THE ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASES (IG-IBD)
2026 · Brigida Barberio, Franco Scaldaferri, et al. · Gastrointestinal Endoscopy
Reference range of pancreatic strain histogram by endoscopic ultrasound elastography: A pilot study
2026 · Carmen Laurenza, Nunzio Zignani, et al. · World Journal of Gastrointestinal Endoscopy
Acnmd26-59: Reference Range of Pancreatic Strain Histograms Using Endoscopic Ultrasound Elastography in Healthy Subjects and Chronic Pancreatitis
2026 · Carmen Laurenza, Nunzio Zignani, et al. · Digestive and Liver Disease
Acnmd26-337: Optimizing Endoscopy: the Impact of Specialist Triage on Diagnostic Accuracy
2026 · Dario Dagani, Luca Pignata, et al. · Digestive and Liver Disease
Acnmd26-442: Bridging the Diagnostic Gap: the Need for Gastric Cancer Screening in High-risk Areas
2026 · Maria Maddalena Sannino, Luca Pignata, et al. · Digestive and Liver Disease
DOP035 Upadacitinib: Personalized Goals for Remission and Disease Evaluation in Patients with Crohn’s Disease (UPGRADE-CD) - A Multicenter Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).
2026 · B Barberio, F Scaldaferri, et al. · Journal of Crohn s and Colitis
Through the lumen-apposing metal stent direct pancreatolithiasis lithotripsy in disconnected duct syndrome: turning an adverse event into an opportunity
2025 · Biagio Elvo, Francesco Frigo, et al. · Gastrointestinal Endoscopy
V.03.1 From Endoscopy to Interventional Radiology: Biliary Recanalization With a Freehand Cystotome of a Strasberg C Bile Duct Injury
2025 · A. Drago, L. Pignata, et al. · Digestive and Liver Disease
Works count: 39
Citation count: 134
H-index: 6
I10-index: 4
Year
Topic
Type